ReviewSensors (Basel, Switzerland)2026
Comprehensive Review of Nystagmus and Vertigo Diagnostics: From Pathological Foundations to AI-Driven Telemedicine.
Review in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nystagmus, the involuntary rhythmic oscillation of the eyes, is a critical diagnostic marker in vestibular medicine, distinguishing life-threatening central disorders such as stroke from benign peripheral conditions including Benign Paroxysmal Positional Vertigo (BPPV). Despite its clinical importance, accurate nystagmus assessment has long been constrained by expensive infrared video-oculography equipment such as videonystagmography, specialist dependency, and the episodic nature of vestibular symptoms that are often resolved before a clinical encounter. This review synthesizes approximately 50 papers published between 1952 and 2026 across four thematic domains: AI-driven nystagmus analysis, clinical medicine, smartphone and portable hardware innovations, and telemedicine and remote monitoring. On the AI front, classical machine learning models achieve up to 98.77% nystagmus recognition accuracy using ensemble methods, while deep learning frameworks spanning CNNs, U-Nets, LSTMs, and optical flow networks demonstrate clinical-grade slow-phase velocity measurement equivalent to gold standard video-oculography on standard smartphone RGB video. Large language and vision models including GPT-4V and Gemini 2.0 show early-stage promise as zero-shot triage tools but currently fall well below specialist-level diagnostic accuracy. Concurrently, portable hardware innovations ranging from 3D-printed goggle systems to ARKit-based smartphone applications are narrowing the accessibility gap, while telemedicine frameworks enable ictal recording and cloud-based specialist review outside the clinic. Across all domains, the common barriers to clinical translation are dataset scarcity for rare BPPV subtypes, sensitivity to ambient conditions, and the absence of explainable AI mechanisms. This review maps the current state of the field and identifies multimodal data fusion, prospective clinical validation, and interpretable AI as the critical next steps toward equitable, specialist independent vestibular diagnostics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.